CureVac founder Ingmar Hörr, here in February 2021, suffered a stroke last March that left him in a coma for weeks.Sebastian Gollnow/DPA/Getty Images BERLIN—Early last year, Ingmar Hörr was at the ...

CureVac AG, a Germany-based drugmaker with a U.S. headquarters in Boston, is changing CEOs for the second CEO time in five days, according to the Boston Business Journal. The biotech company, which is ...

German biotech company CureVac said Wednesday that its founder has withdrawn his candidacy for the supervisory board for health reasons. Dr. Ingmar Hoerr, one of the leading scientists in the ...

CureVac’s embroilment in a crazy story just got a lot weirder: Two weeks back, it lost its CEO, who was without warning replaced by its old CEO. Now, he’s out for the foreseeable future with an ...

CureVac had some disappointing news to report to investors at the J.P. Morgan Healthcare Conference this week after its lead drug failed a phase 2b trial in prostate cancer. The German specialist in ...

Daniel Menichella started the month as CureVac CEO, one of the privileged few to discuss the coronavirus response with U.S. President Donald Trump and kick-starting a vaccine trial against COVID-19.

The German company CureVac hopes its RNA vaccine will rival those made by Moderna and Pfizer-BioNTech. It could be ready next month. By Carl Zimmer In early 2020, dozens of scientific teams scrambled ...

TÜBINGEN, Germany and BOSTON, May 08, 2018 (GLOBE NEWSWIRE) -- CureVac AG, a fully-integrated biopharmaceutical company pioneering the field of mRNA-based drugs, today announced that Founder and Chief ...

This is an archived article and the information in the article may be outdated. Please look at the time stamp on the story to see when it was last updated. German biotech company CureVac said ...

This is an archived article and the information in the article may be outdated. Please look at the time stamp on the story to see when it was last updated. German biotech company CureVac said ...